AI & ML interests

Biological data generation and modeling

Recent Activity

We are a leading AI-driven Contract Research Organization (CRO), revolutionizing drug discovery by uniting advanced high-throughput screening (HTS) capabilities with specialized assay development and CRISPR-based genetic engineering. We offer unparalleled scale and unit economics for perturbation response profiling (DRUG-seq, High Content Imaging) giving customers the ability to screen thousands of compounds and genetic targets.

Check out our blog post with Hugging Face about publishing GDPx1-3 and GDPa1 on the Hugging Face platform!

models 0

None public yet